Kristaps Porziņģis’ absence from the Golden State Warriors’ preseason training camp has drawn widespread attention from US sports media. ESPN highlights his recurring health problems, San Francisco outlets examine the implications for the team, and some commentators are already discussing potential trades. The Warriors, however, have not disclosed the nature of his current health issue or a timetable for his return.
Warriors general manager Mike Dunleavy announced on September 28 that Porziņģis would miss the start of training camp in Hawaii because of a health issue. ESPN reporter Anthony Slater reported that the Latvian center would also miss the preseason opener against the Los Angeles Clippers. Dunleavy did not, however, rule him out for the start of the regular season.
The latest public update offers little additional clarity. An October 2 HoopsHype report, also published by Yahoo Sports, cited journalist Joseph Dycus as saying that head coach Steve Kerr had no new information about Porziņģis’ status. The center remained absent from the team’s training camp.
ESPN’s coverage highlights the contrast between encouraging signs over the summer and his sudden absence at the start of preseason preparations. Porziņģis had been working out at the team’s San Francisco facility the previous week, with the organization optimistic about his readiness. Dunleavy learned of the latest health issue only on Sunday evening, ahead of media day. Slater places the development in the context of Porziņģis’ previous illness-related absences.
A Field Level Media report published by Reuters presents his absence as another setback in the Warriors’ preparations. It emphasizes the surprise expressed by team management and the uncertainty surrounding his return, while drawing attention to his ability to remain available consistently.
San Francisco outlet SFGATE focuses on the questions the team has yet to answer. It recalls Porziņģis’ previously disclosed diagnosis of postural orthostatic tachycardia syndrome, or POTS. Dunleavy has not confirmed that his current absence is related to the syndrome, however. The latest health issue therefore cannot reliably be described as a recurrence of POTS.
The San Francisco Chronicle emphasizes Porziņģis’ importance to the team and the uncertainty created by his health. The newspaper notes that the Warriors agreed to a two-year, $40 million contract with him over the summer. His absence raises fresh questions about how consistently the Latvian center will be able to contribute throughout the season.
A more critical assessment appears in a September 30 commentary by Joey Akeley on Sports Illustrated’s On SI platform. He argues that the recurring uncertainty surrounding Porziņģis’ health should prompt the Warriors to consider trade options. Akeley examines how his contract could be used in a potential deal, but this is a commentator’s proposal: the article does not establish that the Warriors have decided to trade him.
Meanwhile, Golden State is preparing for preseason games without the Latvian center. According to a Roundtable Sports report published by Yahoo Sports, Al Horford is set to start at center in the first preseason game. The Warriors’ regular-season opener is scheduled for October 21 against the Los Angeles Lakers.
As of October 3, neither a precise return date nor a diagnosis for Porziņģis’ current health issue has been publicly announced. The team’s initial statement did not rule him out for the regular-season opener, but the latest reporting provides no clear indication of when he will be ready to return to the court.
